Thursday, March 28, 2024
Home Tags Presents

Tag: Presents

Transforming Industries Sustainably: Frost & Sullivan Institute Presents the 202… –...

0
SANTA CLARA, Calif., Aug. 22, 2023 /PRNewswire/ -- The Frost & Sullivan Institute is thrilled to announce the winners of the prestigious Enlightened...

Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of...

0
Additional analyses support consistent protection from vision lossAnnexon to engage with regulatory agencies to determine optimal path forward for ANX007Company to hold investor...

Mystic Museum of Art (MMoA) Presents From Crisis to Color: DerriHre...

0
Mystic Museum of Art (MMoA) is pleased to present From Crisis to Color: DerriHre le Miroir (Behind the Mirror), an exhibition of original...

ENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in...

0
ENB is developing first in class small molecule ENB-003 to selectively targeting the ETB receptor - a novel immune checkpoint  The ENB-003 in combination...

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Pha… – Press...

0
Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibodyRapid, dose-related,...

Central Florida Lifestyle Magazine Presents the 6th Annual Cutest Toddler Contes…...

0
Central Florida Lifestyle Magazine, a leading lifestyle publication serving Central Florida, today announced the launch of the 6th Annual Cutest Toddler Contest. The...

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83r…...

0
– 30% risk reduction of MACE-4 composite of death from cardiovascular causes, and >25% risk reduction across four key secondary endpoints in primary...

Arrowhead Presents Updated Data from Phase 2 SEQUOIA Study of Investigational...

0
- Data Presented During Oral Session at EASL 2023 Demonstrate Fazirsiran's Promising Impact on Key Markers of Liver Disease - AATD-LD is a Rare...

Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy...

0
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60...

OSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1 and OSE-230 Preclin… –...

0
Regulatory News: OSE Immunotherapeutics SA FR presents scientific updates in oral and poster presentations selected for international conferences: at the Antibody Engineering & Therapeutics...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News